IP Library Granted Patent US 7,449,328
Granted Patent B2
US 7,449,328 · App. 10/929,710 · Granted Nov 11, 2008

Probe matrix-based device for identifying microorganisms

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,449,328
App. No.
10/929,710
Granted
Nov 11, 2008
Kind
B2
Abstract

Device for identifying microbial organisms using a collection of polynucleotide probes, each probe having binding specificity for the ribosomal nucleic acids of at least one microbe. The collection of probes is organized into a series of “addresses” that provide information about the presence or absence of one or more polynucleotide sequences in the biological sample. The system is particularly suited to automated analysis.

Claims (31)

1. A device for detecting nucleic acids, comprising:

a solid support; and

a plurality of addresses disposed on the solid support, each address comprising at least one detectably labeled probe capable of hybridizing to ribosomal nucleic acids from at least one microbial species under high stringency conditions, said plurality of addresses comprising

a first address comprising one or more detectably labeled probes capable of hybridizing to ribosomal nucleic acids of more than one microbial species, and

a second address comprising a mixture of

(a) a first detectably labeled probe capable of hybridizing to ribosomal nucleic acids from a subset of species having ribosomal nucleic acids that hybridize at the first address, and

(b) a second detectably labeled probe capable of hybridizing to ribosomal nucleic acids from a microbial species which does not have ribosomal nucleic acids that hybridize at the first address, but not capable of hybridizing to ribosomal nucleic acids from any microbial species having ribosomal nucleic acids that hybridize at the first address.

2. The device of claim 1 , wherein said subset of species having ribosomal nucleic acids that hybridize at the first address comprises at least one bacterial species having ribosomal nucleic acids that hybridize at the first address.

3. The device of claim 2 , wherein said microbial species which does not have ribosomal nucleic acids that hybridize at the first address comprises a bacterial species which does not have ribosomal nucleic acids that hybridize at the first address.

4. The device of claim 2 , wherein said microbial species which does not have ribosomal nucleic acids that hybridize at the first address comprises a fungal species which does not have ribosomal nucleic acids that hybridize at the first address.

5. The device of claim 1 , wherein said subset of species having ribosomal nucleic acids that hybridize at the first address comprises at least one fungal species having ribosomal nucleic acids that hybridize at the first address.

6. The device of claim 5 , wherein said microbial species which does not have ribosomal nucleic acids that hybridize at the first address comprises a bacterial species which does not have ribosomal nucleic acids that hybridize at the first address.

7. The device of claim 5 , wherein said microbial species which does not have ribosomal nucleic acids that hybridize at the first address comprises a fungal species which does not have ribosomal nucleic acids that hybridize at the first address.

8. The device of claim 1 , wherein each of said at least one detectably labeled probe capable of hybridizing to ribosomal nucleic acids is a detectably labeled soluble probe capable of hybridizing to ribosomal nucleic acids.

9. The device of claim 8 , wherein each of said at least one detectably labeled soluble probe capable of hybridizing to ribosomal nucleic acids comprises a label selected from the group consisting of a chemiluminescent label, a redox-active electron transfer label, and a fluorescent label.

10. The device of claim 9 , wherein each of said at least one detectably labeled soluble probe capable of hybridizing to ribosomal nucleic acids comprises a chemiluminescent label.

11. The device of claim 1 , wherein said first address is selected from the group consisting of:

(a) a pan-bacterial address that hybridizes to ribosomal nucleic acids from a plurality of species of Gram(+) bacteria, a plurality of species of bacteria in the family Enterobacteriaceae, a plurality of species of bacteria in the genus Enterococcus , a plurality of species of bacteria in the genus Staphylococcus , and a plurality of species of bacteria in the genus Campylobacter,

(b) a pan-fungal address that hybridizes to ribosomal nucleic acids from a plurality of fungal species,

(c) a Gram(+) address that hybridizes to ribosomal nucleic acids of a plurality of Gram(+) bacteria, wherein said plurality of Gram(+) bacteria comprise a plurality of bacteria in the genus Staphylococcus,

(d) a family Enterobacteriaceae address that hybridizes to ribosomal nucleic acids from a plurality of bacteria in the family Enterobacteriaceae, and

(e) a Staphylococcus genus address that hybridizes to ribosomal nucleic acids from a plurality of species in the Staphylococcus genus.

12. The device of claim 2 , wherein said at least one bacterial species having ribosomal nucleic acids that hybridize at the first address comprises a species selected from the group consisting of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus pneumoniae.

13. The device of claim 12 , wherein said first address is a family Enterobacteriaceae address that specifically hybridizes ribosomal nucleic acids from a plurality of bacteria in the family Enterobacteriaceae, and wherein said at least one bacterial species having ribosomal nucleic acids that hybridize at the first address comprises Escherichia coli.

14. The device of claim 2 , wherein said first address is a Gram(+) address that specifically hybridizes ribosomal nucleic acids of a plurality of Gram(+) bacteria, and wherein said microbial species which does not have ribosomal nucleic acids that hybridize at the first address comprises Escherichia coli.

15. The device of claim 3 , wherein said first address is a Staphylococcus genus address that hybridizes ribosomal nucleic acids from a plurality of species in the Staphylococcus genus.

16. The device of claim 15 , wherein said at least one bacterial species having ribosomal nucleic acids that hybridize at the first address comprises Staphylococcus aureus.

17. The device of claim 4 , wherein said fungal species which does not have ribosomal nucleic acids that hybridize at the first address comprises Candida albicans.

18. The device of claim 5 , wherein said at least one fungal species having ribosomal nucleic acids that hybridize at the first address comprises Candida albicans.

19. The device of claim 6 , wherein said bacterial species which does not have ribosomal nucleic acids that hybridize at the first address comprises a species selected from the group consisting of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus pneumoniae.

20. The device of claim 7 , wherein said first detectably labeled probe is capable of hybridizing to ribosomal nucleic acids from Candida albicans but not to the ribosomal nucleic acids of other species in the genus Candida.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →